IPO registrations (S-1, F-1) · Registrants
Nuo Therapeutics, Inc.
- SEC CIK
- 1091596 · filings on EDGAR ↗
- Former names
- Nuo Therapeutics, Inc (2014–2014); CYTOMEDIX INC (2000–2014); AUTOLOGOUS WOUND THERAPY INC (2000–2000); AUTOLOGOUS WOUND TRERAPY INC (1999–2000)
- Registration
- Form S-1, first filed 2010-11-19, last 2017-06-30; 7 initial registrations, 8 amendments
- Outcome
- Declared effective 2010-12-08; withdrawal requested 2011-07-18
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 8285 EL RIO, SUITE 190, Houston, TX 77054
- EIN
- 23-3011702
- Ticker
- AURX (OTC)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Nuo Therapeutics, Inc. on the corporate pages
Offering terms
- Proposed price range
- $4.50–$5.50 per share (S-1/A filed 2017-06-30)
- Shares offered
- 2,100,000
- Listing
- Nasdaq under the symbol AURX
- Lead underwriters
- Northland Securities
- Syndicate
- The Benchmark Company
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: CYTOMEDIX, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: NUO THERAPEUTICS, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Nuo Therapeutics, Inc. Fuzzy (name and state)
- Business registration: Nuo Therapeutics, Inc. Fuzzy (name and state)
- Business registration: NUO THERAPEUTICS, Inc. Fuzzy (name and state)
- Business registration: NUO THERAPEUTICS, INC. Fuzzy (name and state)
- Business registration: NUO THERAPEUTICS, INC. Fuzzy (name and state)
- Business registration: NUO THERAPEUTICS, INC. Fuzzy (name and state)
- Business registration: NUO THERAPEUTICS, INC. Fuzzy (name and state)
- Business registration: NUO THERAPEUTICS, INC. Fuzzy (name and state)
- Business registration: NUO THERAPEUTICS, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: NUO THERAPEUTICS, INC. EXACT (EIN (EXACT))
- Form D issuer: Nuo Therapeutics, Inc. EXACT (CIK (EXACT))
- SEC filer: CYTOMEDIX INC EXACT (CIK (EXACT))
- Person page: B Jefferson Clark Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther))
- Person page: C Eric Winzer Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Charles E Sheedy Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner))
- Person page: Scott M Pittman Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,TenPercentOwner))
Filings 39
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2010-11-19 | S-1 | S-1 (registration) | CYTOMEDIX INC | 0001144204-10-062517 ↗ |
| 2010-12-06 | S-1/A | S-1/A (amendment) | CYTOMEDIX INC | 0001144204-10-064981 ↗ |
| 2010-12-08 | EFFECT | EFFECT (declared effective) | CYTOMEDIX INC | 9999999995-10-003498 ↗ |
| 2011-01-26 | EFFECT | EFFECT (declared effective) | CYTOMEDIX INC | 9999999995-11-000259 ↗ |
| 2011-04-12 | S-1 | S-1 (registration) | CYTOMEDIX INC | 0001144204-11-021609 ↗ |
| 2011-05-06 | EFFECT | EFFECT (declared effective) | CYTOMEDIX INC | 9999999995-11-001427 ↗ |
| 2011-05-09 | S-1/A | S-1/A (amendment) | CYTOMEDIX INC | 0001144204-11-027005 ↗ |
| 2011-06-08 | S-1/A | S-1/A (amendment) | CYTOMEDIX INC | 0001144204-11-034685 ↗ |
| 2011-07-18 | RW | RW (withdrawal request) | CYTOMEDIX INC | 0001144204-11-040953 ↗ |
| 2011-07-22 | EFFECT | EFFECT (declared effective) | CYTOMEDIX INC | 9999999995-11-002228 ↗ |
| 2011-11-01 | EFFECT | EFFECT (declared effective) | CYTOMEDIX INC | 9999999995-11-003115 ↗ |
| 2012-04-17 | EFFECT | EFFECT (declared effective) | CYTOMEDIX INC | 9999999995-12-001068 ↗ |
| 2012-04-17 | EFFECT | EFFECT (declared effective) | CYTOMEDIX INC | 9999999995-12-001069 ↗ |
| 2012-04-17 | EFFECT | EFFECT (declared effective) | CYTOMEDIX INC | 9999999995-12-001071 ↗ |
| 2012-11-08 | EFFECT | EFFECT (declared effective) | CYTOMEDIX INC | 9999999995-12-003193 ↗ |
| 2012-11-08 | EFFECT | EFFECT (declared effective) | CYTOMEDIX INC | 9999999995-12-003194 ↗ |
| 2013-06-11 | S-1 | S-1 (registration) | CYTOMEDIX INC | 0001144204-13-034345 ↗ |
| 2013-06-25 | S-1/A | S-1/A (amendment) | CYTOMEDIX INC | 0001144204-13-036502 ↗ |
| 2013-07-17 | EFFECT | EFFECT (declared effective) | CYTOMEDIX INC | 9999999995-13-002101 ↗ |
| 2013-07-17 | EFFECT | EFFECT (declared effective) | CYTOMEDIX INC | 9999999995-13-002102 ↗ |
| 2013-07-17 | EFFECT | EFFECT (declared effective) | CYTOMEDIX INC | 9999999995-13-002110 ↗ |
| 2014-01-09 | S-1 | S-1 (registration) | CYTOMEDIX INC | 0001144204-14-001425 ↗ |
| 2014-01-22 | S-1/A | S-1/A (amendment) | CYTOMEDIX INC | 0001144204-14-003364 ↗ |
| 2014-01-24 | EFFECT | EFFECT (declared effective) | CYTOMEDIX INC | 9999999995-14-000207 ↗ |
| 2014-05-09 | EFFECT | EFFECT (declared effective) | CYTOMEDIX INC | 9999999995-14-001389 ↗ |
| 2014-05-09 | EFFECT | EFFECT (declared effective) | CYTOMEDIX INC | 9999999995-14-001390 ↗ |
| 2014-05-09 | EFFECT | EFFECT (declared effective) | CYTOMEDIX INC | 9999999995-14-001391 ↗ |
| 2014-05-09 | EFFECT | EFFECT (declared effective) | CYTOMEDIX INC | 9999999995-14-001398 ↗ |
| 2014-07-10 | S-1 | S-1 (registration) | CYTOMEDIX INC | 0001144204-14-042342 ↗ |
| 2014-08-12 | EFFECT | EFFECT (declared effective) | CYTOMEDIX INC | 9999999995-14-002489 ↗ |
| 2015-05-13 | EFFECT | EFFECT (declared effective) | Nuo Therapeutics, Inc. | 9999999995-15-001313 ↗ |
| 2015-06-22 | EFFECT | EFFECT (declared effective) | Nuo Therapeutics, Inc. | 9999999995-16-004186 ↗ |
| 2016-11-21 | S-1 | S-1 (registration) | Nuo Therapeutics, Inc. | 0001144204-16-135672 ↗ |
| 2016-12-23 | S-1/A | S-1/A (amendment) | Nuo Therapeutics, Inc. | 0001144204-16-141217 ↗ |
| 2017-01-11 | EFFECT | EFFECT (declared effective) | Nuo Therapeutics, Inc. | 9999999995-17-000078 ↗ |
| 2017-04-11 | S-1 | S-1 (registration) | Nuo Therapeutics, Inc. | 0001437749-17-006388 ↗ |
| 2017-06-21 | S-1/A | S-1/A (amendment) | Nuo Therapeutics, Inc. | 0001437749-17-011557 ↗ |
| 2017-06-30 | S-1/A | S-1/A (amendment) | Nuo Therapeutics, Inc. | 0001437749-17-012109 ↗ |
| 2017-08-04 | RW | RW (withdrawal request) | Nuo Therapeutics, Inc. | 0001437749-17-013817 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2017-06-30 | S-1/A | registration statement | $4.50–$5.50 | 2,100,000 | - | Nasdaq AURX | 2 | primary document; range, shares headline, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Benson James | Director | 9 | 2006–2013 | ||
| CREWS DAVID | Director | 8 | 2006–2009 | ||
| Deva Arun K. | Director | 6 | 2006–2008 | ||
| DROHAN DAVID F | Director | 5 | 2006–2008 | ||
| FYLLING CARELYN P | Officer | VP of Professional Sevices; VP Professional Services; VP PROFESSIONAL SERVICES | 6 | 2006–2009 | |
| Maslan Andrew Scott | Officer | CFO; Chief Financial Officer; CHIEF FINANCIAL OFFICER; Officer | 32 | 2006–2012 | |
| McLoughlin Mark T | Director | 13 | 2006–2015 | ||
| MOHAN KSHITIJ | Director,Officer | Chief Executive Officer | 6 | 2006–2008 | |
| ROSENDALE MARTIN P | Director,Officer; Officer | Chief Executive Officer; CHIEF EXECUTIVE OFFICER; Chief Operating Officer | 28 | 2008–2014 | |
| JORDEN DAVID EMERSON | Director; Director,Officer; Director,Officer,TenPercentOwner; Director,TenPercentOwner | Acting CFO; CEO and CFO; CEO, CFO; CEO/CFO | 142 | 2008–2026 | |
| KEITH STEPHEN | Director | 8 | 2008–2015 | ||
| WINZER C ERIC | Director | 17 | 2009–2026 | person page Fuzzy | |
| MENDELSOHN CRAIG B | Director; Other | 4 | 2009–2012 | ||
| VANEK PATRICK PAUL | Officer | VP of Operations | 2 | 2010–2012 | |
| Field Edward L. | Officer | Chief Operating Officer; CHIEF OPERATING OFFICER | 3 | 2012–2014 | |
| DEL GUERCIO JOSEPH | Director | 9 | 2012–2017 | ||
| HOHNKE LYLE A | Director | 5 | 2012–2015 | ||
| Kent Richard S | Director | 5 | 2012–2014 | ||
| Aldagen Holdings, LLC | TenPercentOwnerOther | 13 | 2012–2015 | ||
| Brooke William W | TenPercentOwnerOther | 13 | 2012–2015 | ||
| Carr Kathryne | TenPercentOwnerOther | 5 | 2012–2015 | ||
| Clark B. Jefferson | TenPercentOwnerOther | 13 | 2012–2015 | person page Fuzzy | |
| SHALLCROSS STEVEN A | Officer | Chief Financial Officer; SEE REMARKS | 5 | 2013–2014 | |
| TOZER DEAN | Officer | Chief Commercial Officer; CHIEF COMMERCIAL OFFICER | 7 | 2014 | |
| CLAUSEN PETER | Officer | CHIEF SCIENCE OFFICER; Chief Scientific Officer; CSO; CSO/COO | 16 | 2014–2026 | |
| Atinsky Lawrence | Director | 4 | 2016–2019 | ||
| Pittman Scott M. | Director; Director,TenPercentOwner | 22 | 2016–2026 | person page Fuzzy | |
| SHEEDY CHARLES E | TenPercentOwner | 12 | 2016–2025 | person page Fuzzy | |
| Boyalife Investment Fund I, Inc. | TenPercentOwner | 2 | 2016–2017 | ||
| Mintz Paul | Director | 10 | 2017–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2025-08-04 | Nuo Therapeutics, Inc. | Other Health Care | $791,418 | $791,418 | 9 | 1 |
| 2024-09-23 | Nuo Therapeutics, Inc. | Other Health Care | $849,125 | $849,125 | 10 | 1 |
| 2024-05-22 | Nuo Therapeutics, Inc. | Other Health Care | $650,875 | $650,875 | 11 | 1 |
| 2023-12-22 | Nuo Therapeutics, Inc. | Other Health Care | $962,500 | $962,500 | 9 | 1 |
| 2023-08-08 | Nuo Therapeutics, Inc. | Other Health Care | $1,035,000 | $1,035,000 | 9 | 1 |
| 2022-05-19 | Nuo Therapeutics, Inc. | Other Health Care | $407,757 | $407,757 | 6 | 1 |
| 2022-05-06 | Nuo Therapeutics, Inc. | Other Health Care | $3,550,000 | $3,550,000 | 26 | 1 |
| 2018-06-12 | Nuo Therapeutics, Inc. | Biotechnology | $500,000 | $500,000 | 1 | 1 |
| 2016-05-20 | Nuo Therapeutics, Inc. | Biotechnology | $10,500,000 | $7,500,000 | 25 | 1 |
| 2012-02-15 | CYTOMEDIX INC | Biotechnology | $21,000,000 | $21,000,000 | 17 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | CYTOMEDIX, INC. | IL | State business registries | EIN (EXACT, as the state registration reports it) |
| Business registration | Nuo Therapeutics, Inc. | TX | State business registries | name and state |
| Business registration | Nuo Therapeutics, Inc. | TX | State business registries | name and state |
| Business registration | NUO THERAPEUTICS, Inc. | TX | State business registries | name and state |
| Business registration | NUO THERAPEUTICS, INC. | TX | State business registries | name and state |
| Business registration | NUO THERAPEUTICS, INC. | TX | State business registries | name and state |
| Business registration | NUO THERAPEUTICS, INC. | TX | State business registries | EIN (EXACT, as the state registration reports it) |
| Business registration | NUO THERAPEUTICS, INC. | TX | State business registries | name and state |
| Business registration | NUO THERAPEUTICS, INC. | TX | State business registries | name and state |
| Business registration | NUO THERAPEUTICS, INC. | TX | State business registries | name and state |
| Business registration | NUO THERAPEUTICS, INC. | TX | State business registries | name and state |
| Form D issuer | Nuo Therapeutics, Inc. | TX | Form D private offerings | CIK (EXACT) |
| Paying company | Nuo Therapeutics | TX | Open Payments (drug and device company payments) | name and state |
| SEC filer | Nuo Therapeutics, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | NUO THERAPEUTICS, INC. | EIN (EXACT) | ||
| Person page | B Jefferson Clark | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther) | |
| Person page | C Eric Winzer | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Charles E Sheedy | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner) | |
| Person page | Scott M Pittman | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,TenPercentOwner) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, TX first:
- LUMINEX CORP TX
- CERENOME, INC. TX
- Apollo Endosurgery, Inc. TX
- LDR HOLDING CORP TX
- OxySure Therapeutics, Inc. TX
- Mobia Medical, Inc. TX
- Soliton, Inc. TX
- Autonomix Medical, Inc. TX
- Acelity Holdings, Inc. TX
- KCI Holdings, Inc. TX
In other datasets, the same topic (Technology) in TX:
- Lobbying client: 3001 INC (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology